These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32449313)

  • 21. Spatial patterns of TDP-43 neuronal cytoplasmic inclusions (NCI) in fifteen cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Cairns NJ
    Neurol Sci; 2011 Aug; 32(4):653-9. PubMed ID: 21647631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
    Kawakami I; Arai T; Hasegawa M
    Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice.
    Medina DX; Orr ME; Oddo S
    Neurobiol Aging; 2014 Jan; 35(1):79-87. PubMed ID: 23954172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.
    Lee S; Jeon YM; Cha SJ; Kim S; Kwon Y; Jo M; Jang YN; Lee S; Kim J; Kim SR; Lee KJ; Lee SB; Kim K; Kim HJ
    Autophagy; 2020 Aug; 16(8):1396-1412. PubMed ID: 31690171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive decline typical of frontotemporal lobar degeneration in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43.
    Caccamo A; Majumder S; Oddo S
    Am J Pathol; 2012 Jan; 180(1):293-302. PubMed ID: 22067910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo.
    Sanna S; Esposito S; Masala A; Sini P; Nieddu G; Galioto M; Fais M; Iaccarino C; Cestra G; Crosio C
    Cell Death Dis; 2020 May; 11(5):369. PubMed ID: 32409664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
    Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
    Prudlo J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.
    Hofmann JW; Seeley WW; Huang EJ
    Annu Rev Pathol; 2019 Jan; 14():469-495. PubMed ID: 30355151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for diseases with TDP-43 pathology.
    Steinacker P; Barschke P; Otto M
    Mol Cell Neurosci; 2019 Jun; 97():43-59. PubMed ID: 30399416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.
    Pottier C; Ren Y; Perkerson RB; Baker M; Jenkins GD; van Blitterswijk M; DeJesus-Hernandez M; van Rooij JGJ; Murray ME; Christopher E; McDonnell SK; Fogarty Z; Batzler A; Tian S; Vicente CT; Matchett B; Karydas AM; Hsiung GR; Seelaar H; Mol MO; Finger EC; Graff C; Öijerstedt L; Neumann M; Heutink P; Synofzik M; Wilke C; Prudlo J; Rizzu P; Simon-Sanchez J; Edbauer D; Roeber S; Diehl-Schmid J; Evers BM; King A; Mesulam MM; Weintraub S; Geula C; Bieniek KF; Petrucelli L; Ahern GL; Reiman EM; Woodruff BK; Caselli RJ; Huey ED; Farlow MR; Grafman J; Mead S; Grinberg LT; Spina S; Grossman M; Irwin DJ; Lee EB; Suh E; Snowden J; Mann D; Ertekin-Taner N; Uitti RJ; Wszolek ZK; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Hodges JR; Piguet O; Geier EG; Yokoyama JS; Rissman RA; Rogaeva E; Keith J; Zinman L; Tartaglia MC; Cairns NJ; Cruchaga C; Ghetti B; Kofler J; Lopez OL; Beach TG; Arzberger T; Herms J; Honig LS; Vonsattel JP; Halliday GM; Kwok JB; White CL; Gearing M; Glass J; Rollinson S; Pickering-Brown S; Rohrer JD; Trojanowski JQ; Van Deerlin V; Bigio EH; Troakes C; Al-Sarraj S; Asmann Y; Miller BL; Graff-Radford NR; Boeve BF; Seeley WW; Mackenzie IRA; van Swieten JC; Dickson DW; Biernacka JM; Rademakers R
    Acta Neuropathol; 2019 Jun; 137(6):879-899. PubMed ID: 30739198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of TDP-43 phosphorylation in aging and disease.
    Eck RJ; Kraemer BC; Liachko NF
    Geroscience; 2021 Aug; 43(4):1605-1614. PubMed ID: 34032984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].
    Hasegawa M; Nonaka T; Yamashita M; Kametani F; Arai T; Yoshida M; Hashizume Y; Tsuchiya K; Akiyama H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):783-5. PubMed ID: 20030209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
    Liu YC; Chiang PM; Tsai KJ
    Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of TDP-43 in the pathogenesis of ALS and FTLD.
    Baralle M; Buratti E; Baralle FE
    Biochem Soc Trans; 2013 Dec; 41(6):1536-40. PubMed ID: 24256250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular dissection of TDP-43 proteinopathies.
    Hasegawa M; Nonaka T; Tsuji H; Tamaoka A; Yamashita M; Kametani F; Yoshida M; Arai T; Akiyama H
    J Mol Neurosci; 2011 Nov; 45(3):480-5. PubMed ID: 21678031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Janssens J; Kleinberger G; Wils H; Van Broeckhoven C
    Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
    Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
    J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [RNA processing TDP-43 protein has a main pathological role in FTLD and ALS].
    Koza P
    Postepy Biochem; 2015; 61(2):159-67. PubMed ID: 26689008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes.
    Prater KE; Latimer CS; Jayadev S
    Glia; 2022 Feb; 70(2):239-255. PubMed ID: 34558120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.